Pular para o conteúdo principal
  • Parceiros aprovados
  • Sobre a ELGA
    • Sobre a ELGA
    • Carreiras
    • Eventos
  • Apoio
    • Planeamento laboratorial
    • Registar um produto
    • Register Your Product (USA & Canada Only)
  • Contacto
  • English
  • Deutsch
  • Español
  • Français
  • Italiano
  • 日本語
  • 中文
Início ELGA LabWater
  • Produtos
    • PURELAB
    • CENTRA
    • MEDICA
    • BIOPURE
    • Gama completa dos produtos ELGA
  • Aplicações
    • Análise microbiológica
    • Bioquímica Clínica
    • Cromatografia gasosa
    • Cromatografia líquida
    • Culturas de célula
    • Eletroquímica
    • Espectrofotometria
    • Espectrometria de massa
    • Espectroscopia Atómica
    • Genética
    • Imunoquímica
    • Requisitos de água para laboratório em geral
  • Tecnologias
    • Carbono ativado
    • Eletrodeionização (EDI)
    • Filtração
    • Osmose Reversa
    • PureSure
    • Troca iónica
    • Ultravioleta
  • Impurezas na água
    • Compostos biológicos
    • Compostos inorgânicos
    • Gases dissolvidos
    • Microrganismos e bactérias
    • Partículas
  • Knowledge
    • Blogue
    • Estudos de caso
    • Água ultrapura
    • Guias e Livros brancos
  • Produtos
    • PURELAB
      • PURELAB® flex 1 e 2
      • PURELAB® flex 3 & 4
    • CENTRA
      • CENTRA® 60/120
      • CENTRA® RDS
      • CENTRA® R200
    • MEDICA
      • MEDICA® 7/15
      • MEDICA® EDI 15/30
      • MEDICA® Pro EDI 60/120
      • MEDICA® Pro-LPS
      • MEDICA® Pro-R e Pro-RE
      • MEDICA® R200
    • BIOPURE
      • BIOPURE 7/15
      • BIOPURE 60/120
      • BIOPURE 200/300/600
    • Gama completa dos produtos ELGA
      • PURELAB® Classic
  • Aplicações
    • Análise microbiológica
    • Bioquímica Clínica
    • Cromatografia gasosa
    • Cromatografia líquida
    • Culturas de célula
    • Eletroquímica
    • Espectrofotometria
    • Espectrometria de massa
    • Espectroscopia Atómica
    • Genética
    • Imunoquímica
    • Requisitos de água para laboratório em geral
  • Tecnologias
    • Carbono ativado
    • Eletrodeionização (EDI)
    • Filtração
    • Osmose Reversa
    • PureSure
    • Troca iónica
    • Ultravioleta
  • Impurezas na água
    • Compostos biológicos
    • Compostos inorgânicos
    • Gases dissolvidos
    • Microrganismos e bactérias
    • Partículas
  • Knowledge
    • Blogue
      • Analytical Chemistry
      • Clinical & Pharma
      • Cool Science
      • Environment and sustainability
      • Life in the lab
      • Purelab product design
      • Science of the future
      • Water Purity
      • Water in the lab
    • Estudos de caso
      • A Abbott Diagnostics escolhe os sistemas ELGA MEDICA no Sul da Ásia
      • Beam Me Up, Scotty: PURELAB® Option Q Delivers Essential Ultra Pure Water
      • Clean Water for a Clean Future
      • Critital Tests Benefit from PURELAB® Option Reliable Pure Water
      • DASA: a maior empresa de diagnósticos médicos do Brasil
      • A ELGA ajuda os laboratórios de imunosserologia a maximizar o tempo de atividade
      • Fondazione Telethon Continues to Choose ELGA Labwater as a Trusted Partner
      • Importância da água ultrapura Tipo 1+ para o desenvolvimento de medicamentos genéricos
      • MEDICA® Pro selecionado para analisadores Siemens ADVIA® no City General Hospital
      • Optimale Wasserqualität für mikrobiologische Forschung und Lehre
      • PURELAB® Option R Guarantees Pure Water for Leading Microfluidics Technology
      • PURELAB® Pulse Delivers Reliable Water Quality and Quantity for a Wide Range of Applications
      • PURELAB® flex: um sistema de formação ideal para o método de investigação atual
      • Powering Cutting-Edge Gene Research
      • Sichere Reinstwasserversorgung für präzise Produkttests
      • Zentrale Reinstwasser-Aufbereitung für Analyser
      • ELGA LabWater and Beckman Coulter Join Forces
      • Applied New Technologies Department Improves ICP, IC & HPLC Sample Turnaround Times with PURELAB®
      • Desvendar os segredos da Antártida com a ajuda de água ultrapura
      • Advancing Genetic Technologies
      • Cross Infection Control: Pure and Simple
      • Researching effective new ways to prevent cardiovascular disease at the University of Columbia
    • Água ultrapura
    • Guias e Livros brancos
      • Pureza da água de HPLC
      • HPLC no setor farmacêutico
      • Redução de riscos clínicos
      • Sustentabilidade
  • English
  • Deutsch
  • Español
  • Français
  • Italiano
  • 日本語
  • 中文
  • Política de privacidade
  • Termos e condições
  • Conformidade legal global
  • Patentes
  • Impressum
  • Início
  • Node
  • Investigating ‘DNA Vaccines’ to Prevent Hepatitis B Infection
Analytical Chemistry

Investigating ‘DNA Vaccines’ to Prevent Hepatitis B Infection

9 nov 2020
- by Dr Alison Halliday

DNA

Nanoparticle delivery systems loaded with an adjuvant and DNA encoding for a viral antigen show promise for genetic immunisation against hepatitis B virus.

An estimated 257 million people are living with chronic hepatitis B infection worldwide. It causes around 887,000 deaths each year, mostly due to cirrhosis and liver cancer. Thankfully, the infection can be prevented through vaccination.

The development of so-called ‘DNA vaccines’ offers an alternative route to immunisation. The idea involves injecting a construct carrying the instructions for the relevant viral antigen into the body (for example, into a muscle) where it is made into the protein that can trigger an immune response.

But a big challenge is around getting the intact DNA constructs into body cells. Different approaches are under investigation, including physical methods such as electroporation (where brief electric pulses are used to boost the uptake of the DNA into cells) – and the use of nanoparticle delivery systems.

Calcium phosphate nanoparticles are particularly attractive due to their combination of high biocompatibility with good biodegradability, along with their small size and high binding affinity to nucleic acids.

Nanoparticle Formulations

In a new study, researchers investigate the potential of using calcium phosphate nanoparticles for genetic immunisation against hepatitis B.1

The scientists prepared nanoparticles loaded with DNA constructs encoding two different proteins: Hep B surface antigen (HBsAg) or enhanced green fluorescent protein (EGFR), which was used as a model to optimise the process. After adding other biomolecules as adjuvants that they hoped would help stimulate the immune system, they added a silica shell to act as a protective coating. 

The researchers took special care to avoid any contamination during the synthesis and purification of the nanoparticles, including using ultrapure water generated from an ELGA PURELAB® laboratory water purification system.

Viral–Specific Immune Response

The researchers initially carried out experiments adding the DNA–loaded nanoparticles to human cervical cancer cells, mouse muscle cells, and hamster kidney cells grown in laboratory dishes. They demonstrated that the DNA successfully got inside the cells and large amounts of the HBsAg protein were made by all three cell types.

They then moved on to experiments in a living system, finding that the nanoparticles successfully induced the injected muscle tissue to produce the HbsAg protein – either by injecting DNA–loaded nanoparticles or with electroporation after injection of the naked DNA alone.

After administering three vaccinations over two–week intervals with HbsAg DNA–loaded nanoparticles, they detected specific antibodies in the bloodstream and an antigen-specific response from certain immune cells in the spleen of the mice. 

Benefits Over Electroporation

This study shows that DNA–loaded calcium phosphate nanoparticles have promising potential to induce a virus-specific immune response in the body against hepatitis B. 

The nanoparticles were almost as efficient as injecting naked DNA followed by electroporation. This should help enhance their potential application, given the short lifetime of nucleic–acid constructs in the body, and problems around acceptance of electroporation for human vaccination.

The hope is that using these nanoparticles will help reduce the dose needed to achieve a similar immune response after intramuscular injection compared with a naked DNA vaccine, applied by electroporation.

Why Choose ELGA LabWater?

At ELGA LabWater, our expert engineers, chemists and scientists are at the forefront of technological innovation. They continue to introduce game-changing features to the lab water market. 

 

Reference:

  1. Rojas–Sanchez, L. et al. Genetic immunization against hepatitis B virus with calcium phosphate nanoparticles in vitro and in vivo. Acta Biomaterialia 2020; 110;254–265. 

 

Dr Alison Halliday
After completing an undergraduate degree in Biochemistry & Genetics at Sheffield University, Alison was awarded a PhD in Human Molecular Genetics at the University of Newcastle. She carried out five years as a Senior Postdoctoral Research Fellow at UCL, investigating the genes involved in childhood obesity syndrome. Moving into science communications, she spent ten years at Cancer Research UK engaging the public about the charity’s work. She now specialises in writing about research across the life sciences, medicine and health.

Quest Download

PURELAB Quest

The only purifier on the market that dispenses all 3 types of science ready water from a compact, economical and easy to use system!

             Click Here To Find Out More

 

  • Enquiry
  • Obter uma cotação
  • Agende uma demonstração
  • Encontre um parceiro aprovado

Enquiry

Please check this to confirm that you have read our Terms of Service and Privacy Policy.

Obter uma cotação

Please check this to confirm that you have read our Terms of Service and Privacy Policy.

Agende uma demonstração

Please check this to confirm that you have read our Terms of Service and Privacy Policy.

Call us

Can't find what you are looking for?

Support Number
+44 (0)20 3567 7300
United Kingdom Sales
+44 (0)1628 879 704
United States of America Sales
+1 877-315-3542
France Sales
+33 1 40 83 65 00
China Sales
+86 400-616-8882

 

Sede da ELGA LabWater

Lane End Business Park
Lane End, High Wycombe
HP14 3BY
Reino Unido
T: +44 (0) 203 567 7300
F: +44 (0) 203 567 7205

Os especialistas em água ultrapura

  • Apoio e serviços
  • Eventos

Estudos de caso

  • Abbott Diagnostics
  • DASA Medical Diagnostics
  • NeoDIN Medical Institute
  • North Staffordshire NHS Trust
  • Olsberg Vocational College

Recursos

  • Saber mais sobre água ultrapura
  • Guias e Livros Brancos
  • Tecnologias de purificação
  • Aplicações
  • Impurezas na água

Blogs

  • Latest Blog
  • Water Purity - Different Types of Pure Water
  • What is Clinical Laboratory Reagent Water (CLSI)?
  • What is Total Organic Carbon (TOC)?
  • Idioma
    • Deutsch
    • English
    • Español
    • Français
    • Italiano
    • Português
    • 日本語
    • 中文
  • Outros sítios Web da Veolia
    • Veolia
    • Veolia Fondation
    • Veolia Water Technologies

© VWS (UK) Ltd. negociando como ELGA LabWater.2021-Todos os direitos reservados.
ELGA é a marca global de água para laboratórios da Veolia.

  • Política de privacidade
  • Termos e condições
  • Conformidade legal global
  • Patentes
  • Impressum
Elga Veolia
TOP

© 2017 ELGA Veolia